1-year clinical outcomes after intravenous rt-PA for Chinese AIS patients (0135-0350)

Study identification

• EU PAS number:
  EUPAS41543
• Study ID:
  50341
• Official title and acronym:
  1-year clinical outcomes after intravenous rt-PA for Chinese AIS patients (0135-0350)
• DARWIN EU® study:
  No
• Study countries:
  China
• Study description:
  No information provided.
• Study status:
  Finalised

Study timelines

Date when funding contract was signed

Planned:01/12/2021

Actual:01/12/2021

Study start date

Planned:01/06/2022

Actual:01/04/2022

Date of final study report

Planned:30/12/2023

Actual:20/02/2023

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Boehringer Ingelheim Int’l Trading (Shanghai) Co., Ltd

Regulatory

• Was the study required by a regulatory body?:
  Unknown
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable